|1.||Claing, Audrey: 3 articles (10/2015 - 12/2008)|
|2.||Schlienger, Sabrina: 2 articles (10/2015 - 01/2014)|
|3.||Haines, Eric: 1 article (10/2015)|
|4.||Yang, Ting: 1 article (05/2014)|
|5.||Zhu, Mingsong: 1 article (05/2014)|
|6.||Ou, Minglin: 1 article (05/2014)|
|7.||Gao, Jieying: 1 article (05/2014)|
|8.||Li, Yuchao: 1 article (05/2014)|
|9.||Zhang, Xiaoqing: 1 article (05/2014)|
|10.||Dai, Yong: 1 article (05/2014)|
02/03/2012 - "AMF-26, a novel inhibitor of the Golgi system, targeting ADP-ribosylation factor 1 (Arf1) with potential for cancer therapy."
06/01/2005 - "[Expression and significance of ADP-ribosylation factor 1 (ARF1) in colorectal laterally spreading tumor]."
06/01/2012 - "ADP-ribosylation factor 1 mRNA was upregulated in tumor tissues (compared with adjacent non-tumor tissues, n = 55) in approximately 67.2% of gastric cancer patients. "
01/01/2010 - "Finally, overexpression of ADP-ribosylation factor 1 (Arf1), a small GTPase essential for the maintenance of the Golgi apparatus, restored Golgi morphology during infection. "
11/01/2007 - "Instead, PLD activity rapidly decreased upon infection and upon ectopic expression of the viral 3A protein, which inhibits the PLD activator ADP-ribosylation factor 1. However, similar decreases were observed during infection with coxsackieviruses carrying defective mutant 3A proteins. "
05/01/2002 - "Infection is strongly inhibited by expression of GTP-restricted ADP-ribosylation factor 1 (Arf1) and Sar1 mutants and by microinjection of antibodies to betaCOP. "
|3.||Breast Neoplasms (Breast Cancer)
10/01/2015 - "We have previously reported that the small GTPase ADP-Ribosylation Factor 1 (ARF1) is highly expressed in invasive breast cancer cells and acts as a molecular switch to activate EGF-mediated responses. "
10/01/2015 - "The small GTPase ADP-Ribosylation Factor 1 mediates the sensitivity of triple negative breast cancer cells to EGFR tyrosine kinase inhibitors."
12/26/2008 - "Using an invasive breast cancer cell lines, we demonstrate that the ADP-ribosylation factor 1 (ARF1), a small GTPase classically associated with the Golgi, is an important regulator of the biological effects induced by epidermal growth factor. "
12/26/2008 - "ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells."
01/01/2014 - "Although we have showed that the GTPase ADP-ribosylation factor 1 (ARF1) is overexpressed in highly invasive breast cancer cell lines and that epidermal growth factor stimulation can activate this ARF isoform to regulate migration as well as proliferation, the role of this small GTP-binding protein has not been addressed in the context of invasiveness. "
|4.||Stomach Neoplasms (Stomach Cancer)
02/15/2006 - "In mice, the Szt1 mutation, which deletes the genomic DNA encoding the KCNQ2 C terminus and all of CHRNA4 (nicotinic acetylcholine receptor alpha4 subunit) and ARFGAP-1 (GTPase-activating protein that inactivates ADP-ribosylation factor 1), reduces seizure threshold, and alters M-channel pharmacosensitivity. "
|1.||GTP Phosphohydrolases (GTPases)
|2.||Epidermal Growth Factor (EGF)
|3.||Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
|5.||Clathrin Heavy Chains
|6.||GTPase-Activating Proteins (GTPase-Activating Protein)
|7.||GTP-Binding Proteins (G-Protein)
|9.||Messenger RNA (mRNA)
|10.||Proteins (Proteins, Gene)